Muscarinic m4 receptor activation by some atypical antipsychotic drugs

Author： Zeng X.P.   Le F.   Richelson E.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.321, Iss.3, 1997-03, pp. : 349-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atypical antipsychotic drugs, diabetes and ethnicity

By Ananth Jambur   Kolli Smitha   Gunatilake Sarath   Brown Steven  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1111-1124

Informa Healthcare

Access to resources Recommend Favorite

Side Effects of Atypical Antipsychotic Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2219-2229

Bentham Science Publishers

Access to resources Recommend Favorite

What's atypical about atypical antipsychotic drugs?

By Meltzer H.Y.  

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite

Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice

By Thomsen Morgane   Wörtwein Gitta   Fink-Jensen Anders   Woldbye David   Wess Jürgen   Caine S.  

Psychopharmacology, Vol. 192, Iss. 1, 2007-05 ,pp. : 97-110

Springer Publishing Company

Access to resources Recommend Favorite

Neurogenic Actions of Atypical Antipsychotic Drugs and Therapeutic Implications

By Newton Samuel S.   Duman Ronald S.  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 715-725

Adis International

Access to resources Recommend Favorite